- Home
- ACIU vs CPZ Comparison
ACIU vs CPZ Comparison
Compare ACIU & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- CPZ
- Stock Information
- Founded
- ACIU 2003
- CPZ 2019
- Country
- ACIU Switzerland
- CPZ United States
- Employees
- ACIU N/A
- CPZ N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- CPZ Trusts Except Educational Religious and Charitable
- Sector
- ACIU Health Care
- CPZ Finance
- Exchange
- ACIU Nasdaq
- CPZ Nasdaq
- Market Cap
- ACIU 332.4M
- CPZ 305.7M
- IPO Year
- ACIU 2016
- CPZ N/A
- Fundamental
- Price
- ACIU $3.17
- CPZ $15.58
- Analyst Decision
- ACIU Strong Buy
- CPZ
- Analyst Count
- ACIU 2
- CPZ 0
- Target Price
- ACIU $12.00
- CPZ N/A
- AVG Volume (30 Days)
- ACIU 146.5K
- CPZ 63.0K
- Earning Date
- ACIU 11-05-2024
- CPZ 01-01-0001
- Dividend Yield
- ACIU N/A
- CPZ 11.07%
- EPS Growth
- ACIU N/A
- CPZ N/A
- EPS
- ACIU N/A
- CPZ N/A
- Revenue
- ACIU $48,505,404.00
- CPZ N/A
- Revenue This Year
- ACIU $85.33
- CPZ N/A
- Revenue Next Year
- ACIU $80.69
- CPZ N/A
- P/E Ratio
- ACIU N/A
- CPZ N/A
- Revenue Growth
- ACIU 4097200.00
- CPZ N/A
- 52 Week Low
- ACIU $2.25
- CPZ $13.17
- 52 Week High
- ACIU $5.14
- CPZ $16.11
- Technical
- Relative Strength Index (RSI)
- ACIU 45.90
- CPZ 53.63
- Support Level
- ACIU $3.10
- CPZ $15.55
- Resistance Level
- ACIU $3.25
- CPZ $15.68
- Average True Range (ATR)
- ACIU 0.14
- CPZ 0.21
- MACD
- ACIU -0.02
- CPZ 0.02
- Stochastic Oscillator
- ACIU 14.47
- CPZ 69.79
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About CPZ Calamos Long/Short Equity & Dynamic Income Trust
Calamos L/S Equity & Dynamic Inc Trust is a trust company which seeks to provide current income and risk-managed capital appreciation. The company invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary and others.